FDA Inspection 1024871 — Imprimis NJOF, LLC
The FDA completed an inspection of Imprimis NJOF, LLC on Jul 10, 2017 in Ledgewood, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jul 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ledgewood, NJ (United States)